Annotation Detail for C9orf140
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of C9ORF140 mRNA | decreases expression | 20106945
20064835
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of C9ORF140 mRNA | decreases expression | 20106945
|
| D015215 |
Zidovudine |
[Zidovudine co-treated with IFNA1 protein] results in decreased expression of C9ORF140 mRNA | affects cotreatment|decreases expression | 20370541
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
5.48 | 9612607 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.06 | 20127859 20464547 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.88 | 6695378 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.73 | 19183758 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.99 | 20146248 17474063 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.14 | 20419170 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.82 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.24 | 19486331 |
| MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
4.33 | 15040536 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.09 | 16530937 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.63 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Zidovudine |
9.63 | 18299183 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.79 | 12639820 12168785 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.96 | 8708960 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.85 | 20471113 |
| MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
5.24 | 12579204 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.16 | 15720958 |
| MESH:D015658 |
HIV Infections |
|
Zidovudine |
3.69 | 20032539 11363243 17358032 11141242 11698656 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.23 | 10903974 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.31 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.56 | 8314463 18776723 10903974 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.88 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
8.88 | 12579204 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.90 | 20370541 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.17 | 21137059 20195826 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.74 | 17053015 6695378 18520028 18816296 20064080 20135361 20869020 20464547 18569708 |
| MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
2.74 | 18800350 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.65 | 16801185 |
| MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
6.71 | 17358032 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.53 | 16381670 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.35 | 11141357 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.31 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.70 | 19348381 18481113 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.64 | 12371664 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.90 | 17292933 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.34 | 16882103 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.54 | 19755658 10029692 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.67 | 20155912 2093021 |
| MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.67 | 17696246 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.31 | 17053015 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.85 | 1336536 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
5.41 | 12579204 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.31 | 17120751 |
Related Pathway Information